• Explore /
  • Poster
  • / Phase 3 PANOVA-3 study: Tumor treating fields (TTFields) therapy concomitant with gemcitabine and nab-paclitaxel (GnP) for front-line treatment of locally advanced pancreatic cancer.

Phase 3 PANOVA-3 study: Tumor treating fields (TTFields) therapy concomitant with gemcitabine and nab-paclitaxel (GnP) for front-line treatment of locally advanced pancreatic cancer.

Abstract Video & Slides Poster

Authors

Hani Babiker

Hani M. Babiker

Mayo Clinic Florida, Jacksonville, FL

Hani M. Babiker , Teresa Macarulla , Philip Agop Philip , Carlos Roberto Becerra , Tomislav Dragovich , Vincent J. Picozzi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT03377491

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS4199)

DOI

10.1200/JCO.2023.41.16_suppl.TPS4199

Abstract #

TPS4199

Poster Bd #

506a

Abstract Disclosures

Similar Posters

First Author: Vincent J. Picozzi

First Author: Vincent J. Picozzi

First Author: Vincent J. Picozzi

First Author: Vincent J. Picozzi